Clinical effect of different concentrations of hypertonic saline with sequential mannitol in treating cranial hypertension after acute massive cerebral infarction

  • WANG Shuqing
Expand
  • Department of Encephalopathy, Guilin Hospital of Traditional Chinese Medicine, Guilin 541002, China

Received date: 2023-05-31

  Online published: 2025-06-12

Abstract

Objective: To compare the efficacy of 3% hypertonic saline(HTS) and 10% HTS combining with 20% mannitol(MT) in the treatment of high cranial pressure after acute massive cerebral infarction. Methods: A total of 40 patients with acute massive cerebral infarction complicated with intracranial hypertension diagnosed and treated by the inpatient Department of Encephalopathy, Guilin Hospital of Traditional Chinese Medicine from 2020 to 2023 were selected in this study. Selected patients were divided into two groups(20 patients in each group) according to random number table method. The treatment group(groupA) was treated with 10% HTS 60 mL and 20% MT 125 mL at alternate static points for cranial pressure reduction(the specific frequency was referred to the adjustment of intracranial pressure), and the control group(groupB) was treated with 130 mL of 3% HTS and 125 mL of 20% MT sequentially. Intracranial pressure(ICP), mean arterial pressure(MAP) and central venous pressure(CVP) were continuously monitored before and after medication in both groups, and the corresponding cerebral perfusion pressure(CPP) was calculated according to ICP and MAP. The duration of effective reduction of intracranial pressure, the maximum reduction and duration of intracranial pressure in enrolled patients were recorded, and the blood sodium value and plasma osmotic pressure were recorded before, 2 and 6 hours after medication. Results: A total of 40 cases were enrolled, with 36 cases completed and 4 cases rejected. The statistical results showed that ICP, MAP, CPP, blood sodium and osmotic pressure were significantly different between the two groups before and after treatment in different periods(P<0.05). After 2 and 6 h of medication, ICP in groupA was lower than that in groupB(P<0.05), while MAP, CVP, CPP, sodium and plasma osmotic pressure were higher than those in the control group(P<0.05). ICP was the most significantly decreased 2 h after treatment(P<0.05), and ICP was the most significantly decreased in the range of 150 to 160 mmol/L of blood sodium(P<0.05). Conclusion: 3% and 10% HTS can effectively reduce ICP in patients with acute large area cerebral infarction, but 10% HTS has more lasting effect on reducing intracranial pressure and less influence on blood sodium and internal environment, which is worthy of clinical promotion.

Cite this article

WANG Shuqing . Clinical effect of different concentrations of hypertonic saline with sequential mannitol in treating cranial hypertension after acute massive cerebral infarction[J]. Journal of Baotou Medical College, 2025 , 41(5) : 68 -71 . DOI: 10.16833/j.cnki.jbmc.2025.05.013

References

[1] Zhao J, Liu RY. Stroke 1-2-0: a rapid response programme for stroke in China[J]. Lancet Neurol, 2017, 16(1): 27-28.
[2] Palestrant D, Frontera JA, Mayer SA. Treatment of massive cerebral infarction[J]. Curr Neurol Neurosci Rep, 2005, 5(6): 494-502.
[3] Jüttler E, Schwab S, Schmiedek P, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery(DESTINY): a randomized, controlled trial[J]. Stroke, 2007, 38(9): 2518-2525.
[4] 黄乾亮, 黎涛, 胡坤. 大骨瓣减压联合内减压治疗大面积脑梗死临床分析[J]. 中国实用神经疾病杂志, 2021, 24(1): 37-41.
[5] 林清国, 杨修, 杨武双, 等. 亚低温治疗自发性脑出血的临床疗效和安全性[J]. 中国临床神经外科杂志, 2018, 23(4): 240-242,245.
[6] 刘洁, 李国, 章淑英, 等. 高渗盐水治疗大面积脑梗死继发脑水肿、颅高压临床研究[J]. 山东医药, 2011 ,51(8): 100-102.
[7] 白映红, 白雅婧, 杨军, 等. 大骨瓣减压术治疗大面积脑梗死25例临床分析[J]. 中国药物与临床, 2021, 21(11): 1917-1918.
[8] 宋梦娇, 张磊, 周美辉, 等. 3%高渗盐水和20%甘露醇治疗重型颅脑损伤合并颅内高压的临床比较观察[J]. 河北医学, 2020, 26(7): 1170-1174.
[9] 孙海滨, 包华. 3%高渗盐水联合甘露醇治疗中等面积脑梗死的临床观察[J]. 中国现代医药杂志, 2019, 21(7): 55-57.
[10] Toung TJ, Nyquist P, Mirski MA. Effect of hypertonic saline concentration on cerebral and visceral organ water in an uninjured rodent model[J]. Crit Care Med, 2008, 36(1): 256-261.
[11] Infanti JL. Challenging the gold standard: should mannitol remain our first-line defense against intracranial hypertension[J]. J Neurosci Nurs, 2008, 40(6): 362-368.
[12] 但慧桃. 交替使用高渗盐水和甘露醇治疗缺血性脑梗死的疗效观察[J]. 海南医学院学报, 2011, 17(1): 82-84, 91.
Outlines

/